Austco Healthcare Limited
Austco Healthcare Limited (AHC.AX) Stock Overview
Explore Austco Healthcare Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
127.4M
P/E Ratio
14.66
EPS (TTM)
$0.03
ROE
0.19%
AHC.AX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Austco Healthcare Limited (AHC.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 69.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.39.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.66 and a market capitalization of 127.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Austco Healthcare Limited, together with its subsidiaries, engages in the manufacture, distribution, marketing, supply, service, and sale of healthcare and electronic communications systems in Australia, New Zealand, Asia, Europe, and North America. It offers Tacera, an IP based nurse call solution for hospitals and aged care facilities. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020. Austco Healthcare Limited was founded in 1986 and is headquartered in Port Melbourne, Australia.
Clayton Astles
102
1/31 Sabre Drive, Port Melbourne, VIC
2004